1 terminated. 1 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 1 | Terminated 1 |
Follow Cardiovascular Events: new trials by email Literature Review of Cardiovascular Events trials Research Report on Cardiovascular Events
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Randomized Controlled Trial of Aliskiren in the Prevention of Major Cardiovascular Events in Elderly People Aliskiren, Amlodipine, Hydrochlorothiazide (HCTZ) - Cardiovascular Events | Phase 3 | Terminated | Novartis Pharmaceuticals | 2336 | 2011-01-01 | 2014-04-08 |
Amlodipine (1) · Hydrochlorothiazide (1) · aliskiren (1)
Argentina (1) · Brazil (1) · Canada (1) · Chile (1) · Colombia (1) · Czechia (1) · Germany (1) · Hungary (1) · India (1) · Ireland (1) · Israel (1) · Malaysia (1) · Netherlands (1) · Philippines (1) · South Africa (1)
2009 (1)